What Is End-of-Life Care for Hepatosplenic T-Cell Lymphoma?
By CRYSTAL BAI •
The short answer: Hepatosplenic T-cell lymphoma (HSTL) is a rare, aggressive lymphoma with a typically short course from diagnosis to end of life. End-of-life care focuses on managing cytopenias, hepatosplenic disease, and systemic symptoms with intensive palliative and hospice support.
Understanding HSTL at End of Life
Hepatosplenic T-cell lymphoma (HSTL) is an extremely rare, aggressive extranodal T-cell lymphoma that primarily involves the liver, spleen, and bone marrow. It disproportionately affects young adults and is associated with immunosuppression (including IBD patients on thiopurines). Most patients relapse after initial chemotherapy and have a poor overall prognosis.
Rapid Disease Course and Palliative Planning
HSTL's aggressive nature means the window for palliative planning is often short. Early, proactive palliative care consultation — even while pursuing active treatment — is recommended. Advance care planning conversations should happen early in the disease course.
Symptom Management
Advanced HSTL involves severe cytopenias (requiring transfusion support), hepatomegaly and splenomegaly causing abdominal pain and early satiety, B-symptoms (fevers, night sweats, weight loss), and infection risk. Hospice care requires teams comfortable with complex symptom management.
Supporting Young Patients and Families
Because HSTL disproportionately affects younger adults, end-of-life support must address the unique dimensions of young adult grief — including impact on partners, young children, and parents grieving out-of-order. Death doulas experienced with young adult end-of-life care are particularly valuable.
Frequently Asked Questions
What is hepatosplenic T-cell lymphoma (HSTL)?
HSTL is a rare, aggressive T-cell lymphoma involving the liver, spleen, and bone marrow, most common in young adults and carrying a poor prognosis.
When should an HSTL patient consider hospice?
Given HSTL's aggressive course, hospice discussions should begin early — typically after first or second relapse when treatment options are exhausted.
What symptoms are managed at end of life with HSTL?
Key symptoms include cytopenias, abdominal pain from organ enlargement, B-symptoms (fever, night sweats), and infection risk.
Can a death doula help young adults and families facing HSTL?
Yes. Death doulas experienced with young adult end-of-life care provide vital support for patients and families navigating HSTL's rapid and devastating trajectory.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.